Herbas VPB

Print
EN | LT
LT - Diagnostiniai žymenys, skirti ląstelių prolifreracijos sutrikimų gydymui telomerazės inhibitoriais
EN - DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12Q 1/68 (nenurodyta)
G01N 33/533 (nenurodyta)
A61K 31/7125 (nenurodyta)
A61K 45/06 (nenurodyta)
G01N 33/574 (nenurodyta)
A61P 35/00 (nenurodyta)
C12Q 1/6886 (nenurodyta)
European patent
(11) Number of the document 2925889
(13) Kind of document T
(96) European patent application number 13858528.6
Date of filing the European patent application 2013-11-27
(97) Date of publication of the European application 2015-10-07
(45) Date of publication and mention of the grant of the patent 2018-09-05
(46) Date of publication of the claims translation 2018-12-27
PCT application
(86) Number PCT/US2013/072302
Date 2013-11-27
PCT application publication
(87) Number WO 2014/085632
Date 2014-06-05
Priority applications
(30) Number Date Country code
201261732263 P 2012-11-30 US
201313802035 2013-03-13 US
201361780851 P 2013-03-13 US
201361798478 P 2013-03-15 US
201361809228 P 2013-04-05 US
Inventors
(72)
BASSETT, Ekaterina, US
BURINGTON, Bart, US
WANG, Hui, US
ENG, Kevin, US
Grantee
(73) Geron Corporation, 149 Commonwealth Drive, Menlo Park, CA 94025, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Diagnostiniai žymenys, skirti ląstelių prolifreracijos sutrikimų gydymui telomerazės inhibitoriais
  DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2024-10-24 12 289.00 EUR
Next renewal fee
2025-11-27
Last update date 2024-10-28